INCB-177054

N/A

Report date: 2025/05/07 11:45:10
NME

Base Information

Drug NameINCB-177054
Drug Alias NameINCB177054INCB-177054
ClassificationOther
Mechanisms of ActionDiacylglycerol kinase alpha inhibitorsDiacylglycerol kinase zeta inhibitors
TargetsDiacylglycerol kinase alphaDiacylglycerol kinase zeta
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesIncyte Corp
China Registration ClassN/A

Develop Information

Active CompaniesIncyte Corp
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A